Prosecution Insights
Prosecution Insights
3 pending office actions • 2 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §102 only | 2 (67%) |
| §112 only | 1 (33%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| SHIAO, REI TSANG | 1 | 79.8% | -34.0% |
| HADDAD, MAHER M | 1 | 50.5% | +54.3% |
| XIAO, YAN | 1 | 67.8% | +51.8% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18275529 | MONOCLONAL ANTIBODY FOR SPECIFICALLY RECOGNIZING GLYPICAN-3, AND APPLICATION THEREOF | HADDAD, MAHER M | — |
| 18267518 | CD5 ANTIBODY AND USE THEREOF | XIAO, YAN | — |
| Art Unit | Apps |
|---|---|
| 1641 | 1 |
| 1642 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18705948 | POLYCYCLIC COMPOUND AS CBL-B INHIBITOR | SHIAO, REI TSANG | — | §102 | Non-Final OA | — | Pending | Apr 29, 2024 |
| 18275529 | MONOCLONAL ANTIBODY FOR SPECIFICALLY RECOGNIZING GLYPICAN-3, AND APPLICATION THEREOF | HADDAD, MAHER M | 1641 | §102 | Non-Final OA | — | Pending | Aug 02, 2023 |
| 18267518 | CD5 ANTIBODY AND USE THEREOF | XIAO, YAN | 1642 | §112 | Non-Final OA | — | Pending | Jun 15, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial